News Features The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations L.A. McKeown December 24, 2020
News Daily News ‘Frailty Meter’ May Aid Treatment Decisions in Chronic Limb-Threatening Ischemia L.A. McKeown November 24, 2020
News Conference News VIVA 2020 BVS Reboot? Signs of Durability to 2 Years in Critical Limb-Threatening Ischemia L.A. McKeown November 11, 2020
News Conference News VIVA 2020 DISRUPT PAD III: Lithotripsy Shows Promise in Heavily Calcified PAD L.A. McKeown November 09, 2020
News Conference News TCT 2020 IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs L.A. McKeown October 18, 2020
News Daily News Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years L.A. McKeown September 17, 2020
News Conference News ESC 2020 VOYAGER PAD: CAD Subanalysis Finds Fewer CV, Limb Events With Rivaroxaban L.A. McKeown September 03, 2020
News Daily News PAD Patients Undertreated With Statins Despite Elevated CV Risk L.A. McKeown July 13, 2020
News Daily News No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort L.A. McKeown June 29, 2020
News Conference News LINC 2020 Algorithm Aims to Help Operators Pair Laser Settings With PAD Lesion Type L.A. McKeown February 06, 2020
News Conference News LINC 2020 DCBs Show Consistent Long-term Benefits in Complex Fem-Pop Patient Subsets L.A. McKeown January 30, 2020
News Conference News LINC 2020 Lutonix BTK Studies: Below-the-Knee Challenges Linger L.A. McKeown January 29, 2020
News Conference News LINC 2020 COMPARE: Similar Efficacy and Safety for Paclitaxel Balloons Regardless of Dose L.A. McKeown January 28, 2020
News Conference News ISET 2020 FDA’s First Take on New Paclitaxel Concerns in CLI Caitlin E. Cox January 24, 2020